leukemia. J Clin Oncol. 2017;35(13):1437-1443. doi:10.1200/JCO.2016.70.22826. Sharman JP,et al.2024 ASH Oral presentation #8867. Mato AR, Shah NN, Jurczak W, et al. Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study. Lancet. 2021;397(10277):892-901. doi:10.1016/S0140- 6736(21)00224-58. Jaypirca. Prescribing Information. Lilly USA, LLC.SOURCE Innovent Biologics## 21% [more press release views with Request a Demo]## Also from this source### Innovent Dosed First Participant ...